BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.

BeEAM - Bendamustine 100 / Etoposide 200 / Cytarabine 200 / Melphalan 140, prior to autologous Stem Cell Transplantation

Protocol-ID: 879 V1.0 (Mini), BeEAM (BEND100/CYTA200/ETOP200/MELP140), before ASCT, NHL/HL


  • Hodgkin Lymphoma; ICD-10 C81.-
  • Mantle Cell Lymphoma; ICD-10 C83.1
  • NHL, B-Cell Type, Anaplastic Large Cell Lymphoma, ALK-Positive; ICD-10 C84.6
  • NHL, B-Cell Type, Diffuse Large Cell; ICD-10 C83.3
  • NHL, B-Cell Type, Follicular grade IIIb; ICD-10 C82.-, C82.7, C82.9


  • A Phase 2 Study from Spanish Geltamo Group Investigating the Efficacy and Safety of Bendamustine As Part of Conditioning Regimen for Autologous Stem-Cell Transplantation in Patients with Aggressive Lymphomas: Second Interim Analysis [URL]
  • Autologous Stem Cell Transplantation with Benda-BEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) in Aggressive Non Hodgkin and Hodgkin´s Lymphoma [URL]
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 28.02.2017